IL7 and neoplasm: After staining with anti-human CD3 FACS antibodies and subsequent flow cytometry analysis, we observed a substantial increase in CD3+ cells within the tumor of the C5/IL7-CAR-T receiving mice group, as shown in Figure 6A.